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Abstract
Background: Plasmodium falciparum genotyping with molecular polymorphic markers is widely
employed to distinguish recrudescence from re-infection in antimalarial drug efficacy monitoring
programmes. However, limitations occur on agarose gel DNA measurements used to resolve the
polymorphisms. Without empirical data, the current distinction of pre- and post-treatment bands,
as persistent or new infection, is subjective and often varying by author. This study measures
empirical tolerance limits for classifying different-sized bands as same or different alleles during
MSP2 genotyping.
Methods: P. falciparum field samples from 161 volunteers were genotyped by nested PCR using
polymorphic MSP2 family-specific primers. Data were analysed to determine variability of band size
measurements between identical MSP2 alleles randomized into different agarose lanes.
Results: The mean (95% CI) paired difference in band size between identical alleles was 9.8 bp
(1.48 – 18.16 bp, p = 0.022) for 3D7/IC and 2.54 (-3.04 – 8.05 bp, p = 0.362) for FC27. Based on
these findings, pre- and post-treatment samples with 3D7/IC alleles showing less than 18 bp
difference corresponded to recrudescence, with 95% confidence, while greater difference indicated
new infection. FC27 allele differences were much narrower. For both 3D7/IC and FC27 amplicon,
allele detection sensitivity was significantly higher with 13 μl compared to 20 μl or 30 μl lane loading
volumes.
Conclusion: During MSP genotyping, it is useful to standardize classifications against measurement
of background variability on identical alleles, in order to obtain reliable findings. It is critical to use
a fixed optimal lane loading volume for constant allele patency, to avoid the disappearance or false
appearance of new infection.
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Background
Increasing resistance to antimalarial therapy is one of the
major obstacles for malaria control worldwide [1-3]. Con-
sequently, surveillance of therapeutic efficacy of these
drugs over time is an essential component of malaria con-
trol.
In endemic areas, the reappearance of asexual erythrocytic
stages of P. falciparum after a correct therapeutic course
may be attributed to either recrudescence of drug-resistant
parasites or a new infection. Molecular genotyping with
MSP1, MSP2 and GLURP polymorphic markers is now
widely used to distinguish recrudescence from re-infec-
tion during in vivo drug efficacy monitoring pro-
grammes[4,5].
Infections can be distinguished by polymerase chain reac-
tion (PCR) fingerprinting. PCR has important potential
advantages for being highly sensitive and specific in
detecting malaria parasitaemia[6]. Comparing pre- and
post-therapy isolates provides information about the
clonality of any persistent infection. However, although
straightforward in principle, the current methods used to
interpret results vary widely[7]. Band size variability
between same alleles can occur on agarose gels. Current
classifications of alleles as same or different are often sub-
jective and varying between authors, with no empirical
data. A recent MMV/WHO consensus report on P. falci-
parum genotyping[8] recommends possible use of poly-
acrylamide gels, capillary electrophoresis, or use of
dedicated fragment sizing software, to increase discrimi-
natory power. However, band size variability between
same alleles can still occur, leading to false categorization
as different alleles. The present study examines band size
variance within and between MSP2 alleles and measures
empirical thresholds for classing infections as same or dif-
ferent.
Methods
Study area and data collection
The study was conducted in a 2000 km2 area from the vicin-
ity of the Malaria Institute at Macha, in Southern Province
of Zambia. The area encompasses four chiefdoms
(Mapanza,  Chikanta,  Macha  and  Muchila), with an esti-
mated population of 180,000 and experiences hyperen-
demic malaria transmission. The study was based on a
simple random sample of 161 thick film-positive residents
of all ages and either sex. Volunteers who gathered at desig-
nated central areas were screened for malaria by micros-
copy. P. falciparum DNA samples were collected by blotting
fingerprick blood from thick film-positives onto Whatman
No 3 MM filter paper as previously described [9].
Informed consent was sought from each participant and
in the case of children, from their guardians. Ethical clear-
ance was obtained from both the national and John Hop-
kins University IRB's.
DNA extraction and PCR
P. falciparum DNA was extracted from air-dried filter paper
blood samples using the chelex method[10,11]. The
extracted DNA was amplified using nested PCR and MSP2
family specific primers as previously described[12]. First-
round PCR primers corresponded to conserved sequences
flanking these regions. Second-round PCR primers were
used to amplify the 3D7/IC and FC27 allelic families of
MSP2[12]. For both primary and secondary reactions a
100 μl total volume was used comprising: 8 μl template,
0.25 μM MSP2 primers, 1.5 mM magnesium chloride, 200
μM dNTP's, 1× PCR Buffer and 4 U of Taq DNA polymer-
ase. PCR annealing cycles for both primary and secondary
MSP2 reactions consisted of an initial two minute dena-
turation step at 94°C, followed by 25 cycles of denatura-
tion at 94°C for 45 seconds, annealing at 61.1°C for 45
seconds and extension at 65°C for one minute[9]. Final
extension was at 65°C for two minutes. The PCR amplifi-
cations were performed in a Thermo Electron®  PX2
(HBPX2) thermal cycler.
Agarose gel electrophoresis
PCR product was resolved by electrophoresis on ethidium
bromide-stained 1.5% agarose gels, on a standard 11 cm
× 9 cm casting tray. Gel thickness was 1.5 cm with well
sizes of 1.2 cm depth × 0.7 cm length × 0.1 cm width.
Duplicate amplicon for each sample was individually ran-
domized and loaded separately in 13 ul volumes per lane
(denoted lane A and lane B). Subsequently, each sample
amplicon was also loaded into randomized single lanes in
20 ul and then 30 ul volumes. Therefore, because of rand-
omization, some duplicate samples were run in adjacent
or non-adjacent lanes. PCR products for 3D7/IC and
FC27 family specific primers were run in separate lanes
and bands were visualized by UV transillumination.
Molecular weight, band mass and intensity were meas-
ured using the Kodak 1D Imaging system.
Statistical analysis
Data were analysed to determine the mean and 95% con-
fidence limits of paired differences in band size between
identical MSP2 alleles randomized into different agarose
lanes. Linear regression was used to study the relationship
between paired band size mean difference and allele size
after controlling for confounders. Potential confounders
included locus used, participants' age and sex, allele inten-
sity, allele mass and streak pattern. Paired-sample t test
was used to determine if means statistically differed by
volume and locus. McNemar's test was used to calculate
MSP2 allele patency by lane loading volume and Wil-
coxon Z test used to compare number of alleles detected.Malaria Journal 2008, 7:185 http://www.malariajournal.com/content/7/1/185
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Results
One hundred and sixty one samples were used to assess
the tolerance limits for band size classifications. All geno-
typing was done using MSP2 with varied volumes of 13 ul,
20 ul and 30 ul. Participants were aged between 2 – 61
years (median 10 years) with an even distribution
between the sexes. Asexual parasite density ranged from 0
– 16560 parasites/μl, with a geometric mean (95% CI) of
364 (119 – 610) asexual parasites/μl.
Inter-lane variability in 3D7/IC and FC27 allele size 
measurements
Despite carrying duplicates of the same amplicon, lane A
and lane B exhibited different band size measurements for
3D7/IC alleles (Figure 1). Mean (95% CI) 3D7/IC allele
sizes were 501.8 bp (481.4 – 522.1 bp) and 516.5 bp
(497.7 bp – 535.3 bp), for the same group of samples in
lane A and lane B, respectively. The paired difference in
band size between identical 3D7/IC amplicon run in lane
A and lane B was 9.8 bp (95% CI: 1.48 – 18.16 bp; p =
0.022). Thus band sizes for identical 3D7/IC alleles dif-
fered by up to 18 base pairs on agarose gels. The mean
band intensity and number of streaked lanes were not sta-
tistically different for lane A and B. The respective mean
intensities (95%CI) of lanes A and B were (135 – 156) pix-
els and 139 (128 – 149) pixels with a difference of 7 (-5 –
19) pixels.
Frequency distribution of 3D7/IC allele sizes (bp) Figure 1
Frequency distribution of 3D7/IC allele sizes (bp). Lane A: based on readings from sample amplicon duplicate rand-
omized into lane A (13 μl loading volume). Lane B: based on readings from sample amplicon duplicate randomized into lane B 
(13 μl loading volume).Malaria Journal 2008, 7:185 http://www.malariajournal.com/content/7/1/185
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Inter-lane variability in FC27 allele size measurements
The mean (95% CI) FC27 allele sizes were 341.0 bp
(322.9 – 359.1 bp) and 346.4 bp (328.5 – 364.3 bp),
respectively for the same samples ran in lane A and lane B.
While the mean (95% CI) paired difference in band size
between identical FC27 alleles was 2.5 bp (-3.97 bp – 8.05
bp; p > 0.362). Although carrying duplicates of the same
amplicon, lane A and lane B exhibited different band size
measurements for FC27 alleles (Figure 2).
MSP2 allele detection in relation to gel loading volume
There were no significant differences in detected allele size
distribution by sample loading volume. Using 13 ul, the
mean (95% CI) 3D7/IC allele sizes were 502.6 bp (95%
CI: 482.4 – 522.7 bp) in lane A; 516.5 bp (95% CI: 497.7
– 535.3 bp) in lane B; 487.3 bp (95% CI: 457.6 – 516.9
bp) in 20 ul lane; and 479.3 bp (95% CI: 448.7 – 509.9
bp) in 30 ul lane (p = 0.182).
Corresponding mean (95% CI) readings for FC27 were
341.0 bp (95%CI: 322.9 – 359.1 bp) in 13 ul lane A;
346.4 bp (95% CI: 328.5 – 364.3 bp) in 13 ul lane B;
345.4 bp (95% CI: 325.4 – 365.4 bp) in 20 ul lane and
350.1 bp (333.1 – 367.2 bp) in 30 ul lane (p = 0.921).
However, for both 3D7/IC and FC27 loci, the mean
number of alleles per sample and the total number of
amplified alleles detected were higher with 13 ul than 20
ul or 30 ul lane loading volumes (Table 1 – Table 2).
Frequency distribution of FC27 allele sizes (bp) Figure 2
Frequency distribution of FC27 allele sizes (bp). Lane A: based on readings from sample amplicon duplicate randomized 
into lane A (13 μl loading volume). Lane B: based on readings from sample amplicon duplicate randomized into lane B (13 μl 
loading volume).Malaria Journal 2008, 7:185 http://www.malariajournal.com/content/7/1/185
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Regression model
The variability seen in paired band size mean difference
was not accounted for by sex, age, allele intensity, allele
mass or locus used.
Discussion
In antimalarial drug efficacy monitoring programmes,
molecular genotyping with MSP1, MSP2 and GLURP pol-
ymorphic markers is widely used to distinguish recrudes-
cence from re-infection. However, one of the current
limitations for this invaluable "PCR correction" is that
similar-sized alleles are often classed as same or different
infections, using subjective visual inspection on agarose
gels. Other workers have adopted a 10 bp cut off point [5]
illustrating arbitrary variability between authors, with no
standardizing experimental data.
The present study ascertained tolerance limits for empiri-
cally classing different-sized bands as recrudescence or re-
infection, during MSP2 genotyping. This classification is
the key basis for identifying drug therapeutic failure from
new infections during in vivo drug efficacy assessments.
The results show that band size measurements for the
same allele can vary appreciably on agarose gels, presum-
ably for varied reasons, ranging from gel running condi-
tions, human error and complexity of infection. Identical
MSP2 alleles could differ in band size, by up to 18 bp for
3D7/IC and 11 bp, for FC27 families. Therefore, visual
distinction of infections is not reliable. For the reported
data, post-treatment alleles exhibiting differences below
these upper limits could thus be classed as recrudescence,
with 95% confidence, while those above these thresholds
could be considered as re-infection.
Neither band size nor lane streaking was significantly dif-
ferent by loading volume. Mean allele size was signifi-
cantly larger for 3D7/IC than FC27 and not dependent on
participants' age or sex, allele intensity or mass. Readings
from a 13 ul loading volume detected significantly more
3D7/IC and FC27 alleles than higher 20 ul and 30 ul vol-
umes.
The current study estimated absolute band size variability
for identical alleles randomized on agarose gel lanes. Dur-
ing routine genotyping for drug efficacy monitoring trials,
pre and post samples are generally placed in adjacent
wells when viewing. This may lead to narrower allele dif-
ferences than reported. Furthermore, the measurements
cannot be generalized for different laboratories and sepa-
ration systems. Individual laboratories would need to
measure within allele variability for their own electro-
phoresis apparatus to standardize their genotyping classi-
fications.
Conclusion
This study shows that it is useful to standardize MSP2 gen-
otyping classifications against measurement of back-
ground band size variability on identical alleles, in order
to obtain reliable findings. Furthermore, a fixed optimal
lane loading volume is critical for constant allele patency,
to avoid the disappearance or false appearance of new
infection.
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Table 2: MSP2 allele patency by lane loading volume.
MSP2 Locus Lane loading volume
13 ul (B) 20 ul 30 ul
3D7/IC 13 μl (A) + - + - + -
+7 9 1 7 4 6 7 3 7
-1 1 2 1 1 0 2
* P 1.000 0.125 0.016
FC27 13 μl (A) + - + - + -
+ 84 2 71 14 65 21
-1 1 1 0 1 0
* P 1.000 0.001 < 0.001
* McNemar's test run for 13 μl lane (A) compared to other lanes. For 
both 3D7/IC and FC27, the number of alleles detected was greatest 
when 13 μl loading volume was used
Table 1: Allele detection per sample by loading volume and MSP2 locus.
Lane loading volume Mean number of alleles per sample [range]
3D7 ψ Wilcoxon Z (P value) FC27 ψ Wilcoxon Z (P value)
13 μl (A) 1.54 [0–4] - 1.45 [0–6] -
13 μl (B) 1.54 [0–3] 0.000 (1.000) 1.44 [0–5] -0.577 (0.564)
20 μl 1.53 [1-4] -1.890 (0.059) 1.22 [0–3] -2.801 (0.005)
30 μl 1.49 [0–4] -2.333 (0.020) 1.12 [0–3] -3.788 (< 0.001)
ψ Paired differences tested against 13 ul lane A.Publish with BioMed Central    and   every 
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